 eros esophag sucralf cimetidin influenc pretreat esophag sphincter pressur serum pepsinogen level forty-eight patient eros reflux esophag sucralf tablet g/day cimetidin g/day week random prospect single-blind cross-ov therapeut trial pretreat esophag sphincter le pressur serum pepsinogen pg-i level possibl predictor drug trial patient sucralf group cimetidin group patient group side effect symptom improv similar extent group endoscop result week treatment sucralf complet heal esophag eros cimetidin improv addit cimetidin differ signific patient drug heal esophag drug crossov le pressur outcom patient sucralf patient refractori le pressur mm Hg good respons -receptor blockad patient esophag sucralf serum pg-i level treatment failur ng/ml vs ng/ml opposit patient cimetidin ng/ml respond ng/ml nonrespond result sucralf valuabl altern inhibitor treatment reflux esophag preliminari evid le pressur pg-i level predict valu respons drug